because this study, like many others, was supported by the drug co. that developed, produces, markets and distributes
Copaxone. So I guess we take the info with a grain of salt, and hope that the study was designed appropriately and objectively, and that results are reported accurately and ethically. If so, and the encouraging results are repeated in future studies, then it really would be great news for Copaxone users.